We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: The approach analyzes commonly captured clinical variables to assign individualized risk for hepatocellular carcinoma (Photo credit: Adobe Stock)

Machine Learning Approach Enhances Liver Cancer Risk Stratification

A machine learning model that estimates liver cancer risk using routine demographic, electronic health record, and blood test data. More...
30 Mar 2026
Image: Schematic illustration of the MetaRing platform for detecting paclitaxel treatment sensitivity in breast cancer (Photo courtesy of HUANG Guangyao)

Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

Researchers have created a biosensor that quickly identifies paclitaxel sensitivity in breast cancer. More...
30 Mar 2026
Image:  DOCK10 may serve as a diagnostic marker for insulin-secreting lesions and a potential therapeutic target in insulinoma (photo courtesy of Institute of Science Tokyo)

Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors

Identification of a molecular mechanism underlying abnormal insulin release could refine insulinoma diagnostics. More...
30 Mar 2026
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

A companion diagnostic now enables selection of patients with esophageal or GEJ carcinoma for pembrolizumab based on tumor PD-L1 expression. More...
30 Mar 2026
Image: The guidance recommends easy‑to‑collect tongue swab samples and a cost‑saving sputum pooling strategy for TB and rifampicin‑resistant TB. (photo courtesy of WHO / Enric Catala Contreras)

WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection

The World Health Organization (WHO) has issued new guidelines emphasizing point-of-care testing for tuberculosis. More...
30 Mar 2026
Image: The assays run on the cobas i 601 analyzer as part of the cobas Mass Spec solution (photo courtesy of Roche)

New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

Roche’s Ionify® steroid assays are its latest mass spectrometry tests to receive CLIA ‘moderate complexity’ classification. More...
30 Mar 2026
Image: The assay serves as an adjunctive tool in evaluating patients suspected of B-cell lymphoproliferative disorders (photo courtesy of Shutterstock)

First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

Invivoscribe's IdentiClone Dx IGH Assay is the first IVDR-certified assay for IGH clonality detection in patients with suspected B-cell lymphoproliferative disease. More...
30 Mar 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Test
Allplex HPV28 Detection
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Copyright © 2000-2026 Globetech Media. All rights reserved.